Celgene Corp (NASDAQ:CELG)

95.26
Delayed Data
As of Feb 16
 -0.88 / -0.92%
Today’s Change
88.32
Today|||52-Week Range
147.17
-8.72%
Year-to-Date

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Celgene Corp have a median target of 126.50, with a high estimate of 163.00 and a low estimate of 96.00. The median estimate represents a +32.79% increase from the last price of 95.26.

Analyst Recommendations

The current consensus among 32 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.95
Sales
$3.5B
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.36%
 
 
 
 
 
 
Growthannually 14.25%
 
 
 
 
 
 

Sales

Growthquarterly -0.59%
 
 
 
 
 
 
Growthannually 13.90%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.